Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29369380 | 1.00 | PTGDR2 (0.32) | PTGDR2AAK1PTPN1PTPN2PTPN11 | |
| SCHEMBL29602017 | 1.00 | PTGDR2 (0.32) | PTGDR2AAK1PTPN1PTPN2PTPN11 | |
| SCHEMBL22823744 | 0.89 | HMGCR (0.30) | — | |
| SCHEMBL29601805 | 0.89 | HMGCR (0.30) | — | |
| SCHEMBL29601942 | 0.86 | PTGDR2 (0.33) | PTGDR2AAK1CYP3A4TSHR | |
| SCHEMBL22823753 | 0.86 | PTGDR2 (0.33) | PTGDR2AAK1CYP3A4TSHR | |
| SCHEMBL22823755 | 0.82 | AAK1 (0.34) | AAK1 | |
| SCHEMBL29368018 | 0.82 | AAK1 (0.34) | AAK1 | |
| SCHEMBL28687061 | 0.82 | AAK1 (0.34) | AAK1 | |
| SCHEMBL31324223 | 0.81 | PTGDR2 (0.36) | PTGDR2AAK1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020254559-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2020-12-24 | — | — | WO | disclosed |